Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during March 2025'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec Limited has filed a routine monthly disclosure with the stock exchange about the number of its shares that were converted from physical certificates into electronic (demat) form during March 2025. Dematerialization is the standard process of moving physical share holdings into a shareholder's demat account, making trading and ownership easier. Such filings are mandatory under exchange rules and are submitted every month to keep investors and the market informed about changes in the company's shareholding format. No specific share counts or other financial details were disclosed in the headline, and this is a procedural compliance update rather than a material business event.
This is a neutral, routine administrative filing with no direct impact on the company's financials, business operations, or stock price. Investors should treat it as standard housekeeping disclosure.